Koninklijke Philips N.V.

NYSE:PHG

Medical - Devices

Healthcare
$29.81 +2.17%

+$0.57 today

Market cap
$29.11B
Beta
0.93
P/E (TTM)
23.1
EPS (TTM)
$1.02
Dividend yield
3.62%
52W Low $22.20High $33.44

Volume 1.45M

Average 1.17M

PHG EBITDA Margin

EBITDA as a percentage of revenue.

Koninklijke Philips N.V.NYSE: PHG

EBITDA Margin · Q2 FY2026 · quarter ended Jun 2026

EBITDA Margin widens to 23.4%

EBITDA Margin was 23.4% in Q2 FY2026, up 7.7 pp from a year earlier. On a trailing-twelve-month basis it was 17.3%, up 6.7 pp year over year. Over 3 fiscal years it widened by 14.2 pp.

Context

  • EBITDA Margin widened in 3 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 10 analysts of 19.8% for the fiscal year ending Dec 2026, up from 14.8% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
23.4%+9.7 pp QoQ
Last fiscal yearDec 2025
14.8%+4.5 pp YoY
LTMJun 2026
17.3%+6.7 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+7.7 pp+3.5 pp-4.2 pp
1 year+4.5 pp+5.0 pp+0.5 pp
3 years+14.2 pp+4.2 pp-10.0 pp
5 years+4.4 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
14.8%
Year-over-year change
+4.5pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How PHG compares with its peers on the latest reported figures

  • PHG's LTM Jun 2026 EBITDA Margin of 17.3% is the 7th highest of the 10 companies compared; the peer median is 21.7%.
  • Its year-over-year change of +6.7 pp is the 2nd highest of 10, against a peer median of +1.0 pp.
  • Over three fiscal years its change of +14.2 pp compares with a peer median of +1.1 pp.
PHG Competitors Peer median
EBITDA Margin for PHG and competitors
Company Period LTM level YoY 3-year change
RMDResMed Inc.LTM Jun 202638.3% +1.0 pp+5.9 pp
IRMDIRadimed CorporationLTM Mar 202637.4% +3.1 pp+5.1 pp
BSXBoston Scientific CorporationLTM Jun 202627.6% +2.2 pp+3.8 pp
MDTMedtronic plcLTM Jul 202627.3% +0.0 pp-0.9 pp
SNNSmith & Nephew plcFY202521.7% -1.3 pp-0.4 pp
ABTAbbott LaboratoriesLTM Sep 202620.1% -6.8 pp-0.3 pp
PHGKoninklijke Philips N.V.LTM Jun 202617.3% +6.7 pp+14.2 pp
GEHCGE HealthCare Technologies Inc.LTM Jun 202615.2% -4.0 pp+1.1 pp
LIVNLivaNova PLCLTM Sep 202614.0% +20.0 pp-12.4 pp
NPCENeuroPace, Inc.LTM Mar 2026-13.9% +3.1 pp+68.3 pp
Peer median (excluding PHG) 21.7%+1.0 pp+1.1 pp

Competitors are the stored peer set for PHG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

EUR
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue17.16B17.83B18.17B18.02B17.83B
Cost of Revenue9.99B10.63B10.72B10.25B9.78B
Gross Profit7.17B7.19B7.45B7.77B8.06B
Gross Margin41.8%40.4%41.0%43.1%45.2%
Research & Development1.81B2.09B1.89B1.75B1.7B
Selling, General & Admin4.86B5.29B5.13B5.07B4.97B
Operating Expenses6.62B8.72B7.56B7.24B6.63B
Depreciation & Amortization1.32B1.6B1.26B1.39B1.13B
EBITDA2B115M1.04B1.85B2.64B
EBITDA Margin11.6%0.6%5.7%10.3%14.8%
Operating Income553M(1.53B)(115M)529M1.42B
Operating Margin3.2%-8.6%-0.6%2.9%8.0%
Interest Income18M25M46M79M108.54M
Interest Expense164M244M306M337M332.34M
Other Income / Expenses(44M)(202M)(412M)(406M)(242M)
Income Before Tax509M(1.73B)(527M)123M1.18B
Pre-Tax Margin3.0%-9.7%-2.9%0.7%6.6%
Income Tax Expense(103M)(113M)(73M)963M282M
Net Income3.32B(1.61B)(466M)(702M)895M
Net Margin19.3%-9.0%-2.6%-3.9%5.0%
EPS (Basic)0.67(1.68)(0.49)(0.75)0.95
EPS (Diluted)0.64(1.68)(0.49)(0.75)0.93
Weighted Avg Shares907.46M952.46M948.79M933.37M962.37M
Weighted Avg Shares (Diluted)950.28M952.46M948.79M933.37M962.5M

Koninklijke Philips N.V.

NYSE:PHG

Intrinsic Alpha fair value

Locked

Current Price

$29.81

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.